news
An α-radioimmunotherapy called 212Pb-anti-CD38 was effective at preventing tumour growth…
7 August 2020 | By Victoria Rees (Drug Target Review)
An α-radioimmunotherapy called 212Pb-anti-CD38 was effective at preventing tumour growth and increasing survival in multiple myeloma tumour-bearing mice, a study has shown.